Almaden Genomics and Elucidata Pair g.nome® with Polly
March 19, 2024
Almaden Genomics partners with Elucidata to integrate Polly’s data harmonization engine into g.nome®, enhancing the solution's dataset diversity and accelerating omics data analysis.
Read More »
Almaden & BigOmics: Omics Data Collaboration
February 22, 2024
Almaden Genomics and BigOmics collaborate to provide end-to-end omics data analysis, integrating Omics Playground with g.nome® for accelerated insights.
Read More »
Almaden Genomics’ g.nome® Further Enhances Single-Cell Analysis
December 13, 2023
Almaden Genomics has incorporated an end-to-end solution to process, analyze, and visualize single-cell RNAseq data.
Read More »
Almaden Adds Pre-built Workflows for faster scRNA-Seq Analysis
October 3, 2023
Almaden Genomics has introduced pre-built workflows for single-cell RNA-seq analysis. This game-changing feature empowers researchers to delve deeper into cellular diversity and disease mechanisms.
Read More »
Almaden Builds Business Operations to Catch up With Technology
June 28, 2023
Almaden Genomics building business operations to keep up with technological innovation
Read More »
Almaden Names Ellen Gordon VP, Head of Business Development
June 6, 2023
Almaden Genomics has named Ellen Gordon as VP, Head of Business Development. She will help Almaden partner with clients to accelerate genomic research.
Read More »
Almaden Genomics Names Board of Advisors
May 31, 2023
Almaden has announced its Board of Advisors, a highly regarded group of healthcare leaders with experience across a variety of industries.
Read More »
OmicsEdge Partners with Almaden to Streamline Drug Discovery
May 18, 2023
A new drug discovery service from OmicsEdge using Almaden's g.nome™ makes it easy for labs to quickly analyze a patient’s medical condition and genomics.
Read More »
Almaden Releases g.nome® with Jupyter Notebook Integration
April 18, 2023
Almaden Genomics has updated its g.nome® platform to integrate with Jupyter Notebook, which will further enable scientists to accelerate genomic discovery.
Read More »